Vor Biopharma announced the appointment of Veit Schmelmer, Ph.D., as Vor’s Senior Vice President of Program and Alliance Management. Dr. Schmelmer has more than 25 years of experience leading the development of novel therapies for cancer, autoimmune disorders and infectious diseases at leading biopharmaceutical companies. Prior to joining Vor, Dr. Schmelmer was most recently Vice President, Project Lead at Magenta Therapeutics.